S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The “Perfect Storm” for Gold (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The “Perfect Storm” for Gold (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The “Perfect Storm” for Gold (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The “Perfect Storm” for Gold (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
Free Trial
NASDAQ:NEXI

NexImmune (NEXI) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free NEXI Stock Alerts
$3.36
+0.06 (+1.82%)
(As of 04/19/2024 ET)
Compare
Today's Range
$3.06
▼
$3.50
50-Day Range
$3.15
▼
$9.94
52-Week Range
$1.25
▼
$28.69
Volume
22,854 shs
Average Volume
36,091 shs
Market Capitalization
$4.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
NEXI stock logo

About NexImmune Stock (NASDAQ:NEXI)

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. The company was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

NEXI Stock Price History

NEXI Stock News Headlines

April 17, 2024 | investorplace.com
NEXI Stock Earnings: NexImmune Reported Results for Q4 2023
April 16, 2024 | theglobeandmail.com
Acute Myeloid Leukemia Market Size is Expected to Grow by 2032 | DelveInsight
April 20, 2024 | Crypto 101 Media (Ad)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
April 15, 2024 | msn.com
Portage mulls company closure, pauses enrolment for lead clinical programme
April 11, 2024 | americanbankingnews.com
Short Interest in NexImmune, Inc. (NASDAQ:NEXI) Decreases By 49.4%
April 2, 2024 | msn.com
Xilio fires 21% of its workforce and reprioritises pipeline
February 7, 2024 | msn.com
NexImmune Announces New Offerings in Recent Press Release
February 6, 2024 | markets.businessinsider.com
NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 20, 2024 | Crypto 101 Media (Ad)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
February 6, 2024 | msn.com
NexImmune Secures Funding Through Equity and Warrant Sales
February 3, 2024 | msn.com
NexImmune Ends Stock Sale Agreement, Raises $5.1 Million
February 2, 2024 | msn.com
NexImmune slips after securities offering
February 2, 2024 | finance.yahoo.com
NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 13, 2024 | nasdaq.com
NexImmune, Inc. Common Stock (NEXI)
January 9, 2024 | investorplace.com
NexImmune (NEXI) Stock Rockets 80% Ahead of Potential Liquidation
December 26, 2023 | bizjournals.com
NexImmune's future in limbo as Gaithersburg biotech extends liquidation vote
December 10, 2023 | ca.finance.yahoo.com
NexImmune, Inc. (NEXI) Stock Price, News, Quote & History - Yahoo Finance
December 1, 2023 | investorplace.com
NEXI Stock Halted: What’s Going on With NexImmune Shares Today?
December 1, 2023 | investorplace.com
Why Is NexImmune (NEXI) Stock Up 353% Today?
November 23, 2023 | morningstar.com
NexImmune Inc Ordinary Shares NEXI
November 8, 2023 | bizjournals.com
Gaithersburg’s NexImmune prepares to shut down, lay off ‘substantially all’ employees
November 6, 2023 | msn.com
What's Going On With Neximmune (NEXI) Stock Monday?
November 3, 2023 | msn.com
Why Neximmune (NEXI) Stock Is Getting Hammered
November 3, 2023 | marketwatch.com
NexImmune Shares Slide Premarket as Biotech Says It Will Liquidate
October 24, 2023 | finance.yahoo.com
NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
October 19, 2023 | finance.yahoo.com
NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
October 18, 2023 | finanznachrichten.de
NexImmune, Inc.: NexImmune Announces 1-for-25 Reverse Stock Split
See More Headlines
Receive NEXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NexImmune and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/12/2021
Today
4/19/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NEXI
CUSIP
N/A
CIK
1538210
Web
www.neximmune.com
Phone
301-825-9810
Fax
N/A
Employees
22
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($30.89)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-62,510,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-216.33%
Return on Assets
-157.05%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.66
Quick Ratio
1.66

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$33.43 per share
Price / Book
0.10

Miscellaneous

Outstanding Shares
1,370,000
Free Float
853,000
Market Cap
$4.60 million
Optionable
Not Optionable
Beta
1.84
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Ms. Kristi Jones R.Ph. (Age 61)
    CEO, President & Director
    Comp: $680.44k
  • Dr. Mathias Oelke Ph.D. (Age 55)
    Chief Scientific Officer
    Comp: $621.26k
  • Mr. John Trainer M.B.A. (Age 50)
    Consultant
    Comp: $546.13k
  • Dr. Jerome Bernard Zeldis M.D. (Age 74)
    Ph.D., Consultant
    Comp: $618.2k
  • Mr. Timothy Stover
    VP, Corporate Controller and Principal Financial & Accounting Officer
  • Mr. Karen Haslbeck
    Head of Human Resources
  • Dr. Daniel P. Bednarik
    Senior Vice President of Molecular Engineering & Protein Design
  • Dr. Robert Douglas Knight M.D. (Age 73)
    Chief Medical Officer
    Comp: $454.77k
  • Mr. Chad Rubin
    Senior Vice President of Corporate Affairs
  • Dr. Jack A. Ragheb M.D.
    Ph.D., Senior Vice President of Translational Science

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NEXI Stock Analysis - Frequently Asked Questions

How have NEXI shares performed in 2024?

NexImmune's stock was trading at $2.22 on January 1st, 2024. Since then, NEXI shares have increased by 51.4% and is now trading at $3.36.
View the best growth stocks for 2024 here.

Are investors shorting NexImmune?

NexImmune saw a drop in short interest in March. As of March 31st, there was short interest totaling 17,800 shares, a drop of 49.4% from the March 15th total of 35,200 shares. Based on an average daily trading volume, of 1,160,000 shares, the short-interest ratio is currently 0.0 days. Approximately 2.3% of the company's shares are short sold.
View NexImmune's Short Interest.

When is NexImmune's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our NEXI earnings forecast.

How were NexImmune's earnings last quarter?

NexImmune, Inc. (NASDAQ:NEXI) announced its quarterly earnings results on Friday, November, 12th. The company reported ($16.25) earnings per share for the quarter, topping analysts' consensus estimates of ($16.75) by $0.50.

When did NexImmune's stock split?

NexImmune shares reverse split on the morning of Thursday, October 19th 2023. The 1-25 reverse split was announced on Wednesday, October 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

When did NexImmune IPO?

NexImmune (NEXI) raised $75 million in an initial public offering on Friday, February 12th 2021. The company issued 4,700,000 shares at $15.00-$17.00 per share. Barclays, Cantor, Raymond James and Allen & Co. served as the underwriters for the IPO.

How do I buy shares of NexImmune?

Shares of NEXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NEXI) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends